Volitionrx VNRX
NYSE VNRX
$0.17 -0.01 (-3.98%)
As of: Oct 21, 2026 · 11:37 AM EDT

Volitionrx (VNRX) Convertible Debt (2025 - 2026)

Updated

Volitionrx (VNRX) posted Convertible Debt of $239,807 for Q2 2026, down 91.8% from $2.92 million a year earlier.

Analysis

Volitionrx (VNRX) Convertible Debt (2025 - 2026) Analysis & Trends

At the end of FY2025, Volitionrx's Convertible Debt came in at $1.44 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 260.30 Bn 239.33 Bn 4.88 Bn
2 Abbott Laboratories 170.90 Bn 141.33 Bn 7.27 Bn
3 Danaher 164.81 Bn 148.62 Bn 3.61 Bn
4 Intuitive Surgical 152.46 Bn 131.89 Bn 1.96 Bn
5 Medtronic 119.28 Bn 84.53 Bn 6.34 Bn
6 Stryker 112.91 Bn 99.03 Bn 4.50 Bn
7 Boston Scientific 64.87 Bn 59.63 Bn 3.85 Bn
8 Becton Dickinson 53.24 Bn 50.39 Bn 2.32 Bn
9 Edwards Lifesciences 50.42 Bn 34.43 Bn 1.35 Bn
10 Volitionrx 596,589.45 -5.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 239,807.00
Dec 31, 2025 1.44 Mn
Sep 30, 2025 2.26 Mn
Jun 30, 2025 2.92 Mn
API Access

Volitionrx Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=VNRX&period=max&api_key=YOUR_API_KEY